Generic Companies with Tentative Approvals for: Hetero Labs Ltd Iii
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Hetero Labs Ltd Iii Generic Filers with Tentative Approvals
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Applicant | Generic Name | NDA | Strength | Dosage Form |
---|---|---|---|---|
Hetero Labs Ltd Iii | dabigatran etexilate mesylate | 207961 | EQ 150MG BASE | CAPSULE;ORAL |
Hetero Labs Ltd Iii | raltegravir | 203540 | 400MG | TABLET;ORAL |
Hetero Labs Ltd Iii | lamivudine; tenofovir disoproxil fumarate | 207315 | 75MG;75MG | TABLET;ORAL |
>Applicant | >Generic Name | >NDA | >Strength | >Dosage Form |